|Seven Johannes Sam|| AGHDASSI|
|Fernando|| BELLISSIMO-RODRIGUES |
|Yehuda|| CARMELI |
|Catherine T.|| COOPER|
|Marlieke|| DE KRAKER|
|Marcela|| HERNANDEZ DE MEZERVILLE |
|Claire|| KILPATRICK |
|Liz|| KINGSTON |
|Marjolein|| KLUYTMANS-VAN DEN BERGH|
|Amy|| KOLWAITE |
|Caroline|| LANDELLE |
|Moi Lin|| LING|
|John|| ROSSEN |
|Wing Hong|| SETO |
|Josiane|| SZTAJZEL |
|Maaike|| VAN MOURIK|
|Last Name||First Name||Photo||Bio||Bio Photo|
|AGHDASSI||Seven Johannes Sam||Department of hygiene and environmental medicine, Charité-University Medicine, Berlin, GermanyFamily name: AghdassiGiven names: Seven Johannes SamDate of Birth: 03.05.1988 Nationality: GermanProfession: Medical doctorEducation: 2007: Graduation from German "Gymnasium" with "Abitur"2008-2014: Medical student at Charité-University Medicine BerlinJune 2014: Doctorate in MedicineCareer:November 2014 - Oktober 2015: Medical doctor at Charité-University Medicine Berlin in the department of nephrology and medical intensive careSince January 2016: Medical doctor at Charité-University Medicine Berlin in the department of hygiene and environmental medicineLaguages:German (native speaker)English (fluent in spoken and written) Spanish (fluent in spoken and written) French (basic knowledge) Disclosure of Interest: None Declared|
|AIKEN||Alexander||Department of Infectious Diease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Alexander Aiken is an infectious diseases epidemiologist working at the London School of Hygiene & Tropical Medicine. His main interests are in hospital acquired infections and antibiotic resistance in Low and Middle Income Countries, especially sub-Saharan Africa. During his PhD, he worked in Kenya on the epidemiology of Surgical Site Infections, paediatric nosocomial bacteraemia and MRSA carriage. He is now conducting pilot studies to plan for a major cluster-randomized trial of a hand-hygiene intervention in hospitals in Zimbabwe. Disclosure of Interest: None Declared|
|ALTAF||Arshad||Dr Arshad Altaf is a physician and a public health practitioner trained in Pakistan and the United States. He is currently working as a Consultant and focal person for the injection safety in WHO headquarters in Geneva. Started in 2015, the global injection safety campaign of WHO is concentrating on three countries including India, Uganda and Egypt. Dr Altaf has been closely working with the WHO country offices of these three countries and ministries of health and their hepatitis programmes providing technical assistance in implementation strategies. He has closely worked with the injection safety initiative of WHO since it started in early 2000s. The initial research work on development of injection safety tools was spearheaded by him. He advocates for a multi prong strategy to improve injection safety as he believes that there is no quick fix to the problem. He is also concerned about the transmission risks of hepatitis C in particular due to unsafe medical injections in some of the high burden countries. Dr Altaf has multiple publications in peer reviewed journals on injection safety not only highlighting the problem but suggesting strategies to improve the problem.|
|ASSADIAN||Ojan||Institute for Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, United KingdomUniv.-Prof. Dr. Assadian was born in Vienna, Austria. He received a medical degree from the University of Vienna, Austria, in 1997 and a Diploma in Tropical Medicine and Hygiene, from the London School of Hygiene and Tropical Medicine, in 2000. ysis, and interpretation of nosocomial infections and pathogens with special resistance and virulence factors“. In October 2004, he was awarded tenure track Professor at the Medical University of Vienna. Since 2005 he worked for the Medical University of Vienna as Senior Clinical Specialist and Chairperson of the Infection Prevention and Control Committee at Prince Court Medical Centre, Kuala Lumpur, Malaysia. In 2008, he became interim. Head of the Division of Hospital Hygiene/ Clinical Institute for Hygiene and Medical Microbiology at the Medical University of Vienna. In 2011 he returned to Vienna and continued his clinical work as Consultant Infectious Diseases & Tropical Medicine and Consultant Clinical Microbiology & Infection Control at the Medical University of Vienna and the Vienna General Hospital, a 2,200 bed university teaching hospital. In 2015, he was appointed as Professor of Skin Integrity and Infection Prevention at the University of Huddersfield, England, where his research and teaching work focuses on diagnostic, treatment and prevention of infection, including wound infections. Since 2012, he is President of the Austrian Society for Infection Control. His research interests focus on epidemiology of healthcare-associated infections, wound infection, prevention of surgical site infection, characteristics and clinical application of antiseptics, medical use of low-temperature plasma, and infection control aspects of hospital construction as well as antimicrobial medical devices. He is reviewer of international journals, editor and author of two reference text books in the field of infection control, and author of more than 190 published peer-reviewed articles in international medical journals. Disclosure of Interest: O. Assadian Grant/Research support from: FIEW - Foundation for Innovation and Education in Wound Management, Schulke&Mayr GMBH, Becton Dickinson Ltd., , Speakers' bureau of: Quantum Management & Service GmbH, Consultant for: GLG Consultants, Altrazeal Europe Ltd., Antiseptica chem. GmbH, B. Braun Melsungen AG, Ethicon Ltd., Mundipharma GmbH, Other conflict with: Mölnlycke Medical Advisory Board, Hutchinson santé’s medical advisory board|
|BELLISSIMO-RODRIGUES||Fernando||Social Medicine, University of São Paulo, Ribeirão Preto, Brazil Fernando Bellissimo-Rodrigues is a medical doctor and an infectious diseases specialist with a special interest in hospital epidemiology and infection control, topics in which he has been trained at the University of Geneva Hospitals, under the supervision of Prof. Pittet. Currently, he works as an Associate Professor of the RibeirãoPreto Medical School, University of São Paulo, Brazil, and is the Coordinator of the WHO Implementation Research Regional Training Centre for the Region of Americas. Disclosure of Interest: None Declared|
|BISCHOFF||Peter||Medical Education at Freiburg University, Germany, Mainz University, Germany, and Université de Paris Sud XI, France. After residency in ear-nose-throat surgery, Dr. Bischoff currently is research fellow in infection control and prevention at Charité University Medical Center in Berlin, Germany. The work includes research in hospital epidemiology, coordination of infection control activities within the university medical center, project manager of nationwide surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant, medical education and lecturing. Technical assistance to WHO Service Delivery & Safety and Infection Prevention & Control unit in the development of the WHO Guidelines for the Prevention of Surgcial Site Infections under the lead of Prof. Allegranzi. Disclosure of Interest: None Declared|
|BONTEN||Marc||University Medical Center Utrecht, Ultrecht, Netherlands Marc Bonten (born 16-10-1964) got his MD (1991) and PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University Medical School, the Netherlands. He registered as internist in 2000, as infectious disease specialist in 2002 and as clinical microbiologist in 2008, all at the University Medical Center Utrecht, the Netherlands. Since August 2008 he is head of the department Medical Microbiology and leading the research group of infectious Disease Epidemiology of the Julius Center of Health Sciences and Primary Care, both at the UMC Utrecht, where he is professor of molecular epidemiology of infectious diseases since 2002. He has been a principal investigator in many large scale epidemiologic studies and investigator-initiated randomized trials of prevention and treatment of infectious diseases. His experience covers the full range of epidemiologic study designs including clinical trials, cohorts, case-control studies and mathematical modelling. Marc Bonten has been (co-)applicant of a large number of grants from (national) research councils, EU and pharmaceutical companies. He is a VICI laureate (2006) from the Dutch Science Association and Excellence Award winner of ESCMID (2015), coordinator of the EU-funded project R-GNOSIS and scientific coordinator of the IMI-funded consortiums COMBACTE, COMBACTE-CARE and COMBACTE-MAGNET. Disclosure of Interest: None Declared|
|BOYCE||John||Dr. Boyce is currently President of J.M. Boyce Consulting LLC, a position he assumed after retiring from his positions as Director of Hospital Epidemiology & Infection Control at Yale-New Haven Hospital in New Haven, CT and as Clinical Professor of Medicine at the Yale University School of Medicine in 2015. He served as President of the Society for Healthcare Epidemiology of America (SHEA) in 1999. He was co-author of the CDC Guideline for Hand Hygiene in Healthcare Setting, and served as a member of the hand hygiene committee of the WHO, which published the WHO Guidelines for Hand Hygiene in Health Care in 2009. During his 35 years of experience as hospital epidemiologist, he has investigated the causes of, and developed control measures for, numerous outbreaks and pseudo-outbreaks, including several related to endoscopic procedures.|
|CARMELI||Yehuda|| CURRICULUM VITAE: YEHUDA CARMELI, M.D, M.P.H. |
Professor in Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel. Head, Division of Epidemiology and the National Institute for Infection Control and Antibiotic Resistance, Tel Aviv Sourasky Medical Center, Israel. Affiliation: 1. Division of Epidemiology and the National Institute for Infection Control and Antibiotic Resistance, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv, 64239, Israel. 2. Sackler Faculty of Medicine, Tel Aviv University, Israel A. ACADEMIC DEGREES: 10/1989 MD, Ben Gurion University of the Negev, Beer Sheva, Israel. 6/1998 MPH, Harvard School of Public Health, Boston, MA. B. ACADEMIC APPOINTMENTS: 2000-2015 Lecturer in Medicine, Harvard Medical School, Boston, MA 2011- Professor in Medicine, Sackler Faculty of Medicine, Tel Aviv University, Israel C. CLINICAL EXPERIENCE: 1989-1993 Resident Physician, Department of Internal Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel. 1993-1994 Resident Physician, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. 1994-1998 Fellow, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA. 1998- Staff physician, Division of Infectious diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 1999- Head, Division of Epidemiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 2000-2015 Research staff physician, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA. 2008- Head, National Institute infection Control and Antibiotic Resistance . Disclosure of Interest: None Declared
|CASTRO-SANCHEZ||Enrique||Enrique is the lead Academic Research Nurse at the Health Protection Research Unit, and was recently appointed as Antimicrobial Research Collaborative (ARC) Research Fellow to study the development and implementation of innovative roles for nurses in antimicrobial stewardship. His work explores the combination of behavioural sciences and technological innovations to sustain clinician engagement with optimal infection prevention and control and antibiotic prescribing behavior. Enrique is also keen to explore the influence of health literacy in decisions about healthcare-associated infections and antimicrobial stewardship, the impact of health inequalities on infectious diseases, policy influence on management of infectious diseases and the effect of social networks on clinicians and patients’ attitudes to infection. Enrique’s clinical experience includes tuberculosis, tropical medicine, sexually transmitted infections and HIV, and he has been the national lead for HIV at the Royal College of Nursing in the UK. Enrique completed his PhD (cum laude) at the Universitatd’Alacant in Spain in 2015, and received an MSc in Public Health and Diploma in Tropical Nursing from the London School of Hygiene and Tropical Medicine. He was selected in 2016 as an Emerging Leader in International Infectious Diseases by the International Society for Infectious Diseases.”|
|CHENG||Vincent C.||Microbiology, The University of Hong Kong, Hong Kong, Hong Kong. Vincent Chi-Chung Cheng is currently Consultant Microbiologist and Infection Control Officer at Queen Mary Hospital, Hospital Authority, Hong Kong Special Administrative Region, and Honorary Professor at Department of Microbiology, The University of Hong Kong. He graduated from the Faculty of Medicine at The University of Hong Kong in 1994 with distinction in Medicine, and trained in the field of internal medicine. After acquisition of Membership from The Royal Colleges of Physicians of the United Kingdom in 1997, he pursued further training in Clinical Microbiology and Infectious Diseases at Queen Mary Hospital. He also received training in Clinical Infectious Diseases and HIV medicine under the tutelage of Davidson Hamer, David Snydman, and Sherwood Gorbach at Tufts Medical Center, Boston, USA in 2001. He obtained his Membership and Fellowship from The Royal College of Pathologists in 2004 and 2007 respectively. He was conferred Doctor of Medicine by The University of Hong Kong in 2012, and was awarded the Sir Patrick Manson Gold Medal for the best MD thesis. He has published over 200 international peer reviewed original articles in the areas of clinical infectious disease including SARS and influenza, diagnostic clinical microbiology, proactive infection control for multiple drug resistant bacteria, and respiratory and gastrointestinal viruses, and hospital outbreak investigations for bacteria, virus, and fungus. Disclosure of Interest: None Declared|
|CHRAITI||Marie-Noëlle|| Infection Control Programme, University of Geneva Hospitals, Geneva, Switzerland|
A Short, selective and informal biography Senior infection control nurse at the University of Geneva Hospitals who has got the chance, among other opportunities of ICP
- to practice the old fashion isolations and universal precautions and then, to adapt, promote, teach and train on Standard precautions
- to collaborate on the WHO programme Clean Care is Safer that has enlarged my understanding of ICP outside a high resources hospital and health system
- to scrutinize PPE use very carefully while developing and testing recommandations and procedures for care to the patient with Ebola disease in Geneva University Hospitals Three areas of experience that may explain my presence here!
Disclosure of Interest: None Declared
|CONLY||John||A graduate of the University of Saskatchewan (Distinction), John Conly is medically trained ininternal medicine and infectious diseases and is Board certified in both Canada and the UnitedStates. He is the past Chairman of the Department of Medicine, University of Calgary andAlberta Health Services, past President of the Canadian Infectious Disease Society, past BoardChairman for the Canadian Committee on Antibiotic Resistance, the inaugural Vice Chair for theCanadian Expert Drug Advisory Committee and founding Co‐Chair for the Canadian HospitalEpidemiology Committee which in collaboration with the Public Health Agency of Canadaestablished the current Canadian Nosocomial Infection Surveillance Program. He is currentlythe Co‐Director for the Snyder Institute for Chronic Diseases at the University of Calgary, theEditor‐in‐Chief for the Journal of the Association of Infectious Diseases and MedicalMicrobiology, an Academic Editor for PLoS One and a member of the WHO Advisory Group onIntegrated Surveillance of Antimicrobial Resistance. He has published over 300 papers and hasreceived multiple career honours in teaching, research, mentorship, innovation and service. Hewas the recipient of the Ronald Christie Award in 2012 from the Canadian Association ofProfessors of Medicine which is awarded to a former Chair of a Canadian Department ofMedicine who has made outstanding contributions to academic medicine in Canada. Hecontinues as an active consultant in clinical infectious diseases and his current interests focuson antimicrobial resistance, patient safety and innovations in healthcare.|
|COOPER||Catherine T.||I am Dr. Catherine Thomas Cooper a medical doctor who resides in Monrovia, Liberia, West Africa. I have had fifteen years of experience working as a medical doctor in various areas of medical practice.I have six years of clinical practice, with five years of emphasis in the area of pediatric medicine. Additionally I have nine years’ experience in the area of public health with particular skill in programmatic management, disease control and 4 years’ experience in infection prevention and control. I am employed with the Ministry of Health of Liberia. I affiliate with the Liberia Medical and Dental Association and served as a member of the executive council for six years. I also serve as a member of the National Polio Expert committee.IobtainedaBachelor’s of Science in Biology from the Cuttington University College, Liberia (1989) and my doctor in medicine from the A.M.Dogliotti College of Medicine, University of Liberia (2001). I worked in the following positions over the last four years:Program Manager, National Leprosy& TB Control Program, Ministry of Health (2008-2014);Master trainer IPC, Ebola task force (2014-2015); Chair person, Infection prevention and control task force, Ebola Response(2014-2015) and Director, Quality Management Unit, Ministry of Health (2015-2016): Assistant Minister for Curative Services, Ministry of Health (2016). I have worked with several international partners and donor agencies on disease prevention and control. I have skills in strategic planning and management with the ability to manage large funding. I have skills and experience in IPC due to the recent Ebola epidemic in Liberia. Disclosure of Interest: None Declared|
|DAMANI||Nizam||MSc (London, England), MBBS (Karachi, Pakistan), FRCPath (London, England), FRCPI (Dublin, Ireland), CIC (USA), DipHIC (Lond). Dr Nizam Damani is ex- Associate Medical Director of Infection Prevention and Control (IPC) at the Southern Health & Social Services Trust, an honorary lecturer in Medical Microbiology at Queens University, Belfast, UK and senior consultant at the World Health Organization HQ in Geneva. He trained and worked in Karachi, Nairobi, London, Belfast and Geneva. He is an internationally recognized expert in the field of IPC in healthcare facilities both in low- to middle and high income countries. He was member of the WHO core group of the 1st Global Patient Safety Challenge ‘Clean Care is Safer Care’ and was the country co-ordinator for the WHO pilot site for the implementation of the Hand Hygiene programme. He has served on various project boards, working parties and steering groups both at national and international level both for governmental bodies and organizations including Dept. of Health (N. Ireland, UK), European Union and WHO. He is the founder member of the Infection Control Society of Pakistan, was a member of the International Faculty Board IC Programme, Ministry of Health in Egypt. He was a member of the British Society of Antimicrobial Chemotherapy National Working Party of Antibiotic Sensitivity testing method. He also served as Treasurer of the International Federation of Infection Control (IFIC). He has made presentations at many national and international meetings, often as an invited and speaker and given state of the art and key note lectures. He has published extensively in scientific peer-reviewed journals. His is the sole author of Information Resources in Infection Control (8th edition) and Manual of Infection Prevention and Control (3rd edition) which has been published by the Oxford University Press and has been translated in various languages. Disclosure of Interest: None Declared|
|DE KRAKER||Marlieke|| Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland|
Marlieke de Kraker earned her Master of Science degree in Epidemiology, including a minor in Infectious Diseases, in 2004 at the Radboud University Nijmegen, The Netherlands. She worked as an epidemiologist at the Netherlands' Institute for Public health and the Environment for 8 years. Here she was part of the Management Team of the European Antimicrobial Resistance Surveillance System (now EARS-Net), was involved in national antimicrobial resistance (AMR) surveillance activities, outbreak investigations and a prospective cohort study to look at ESBL-carriership among healthy adults. In the same institute, she carried out her PhD on the burden of AMR in Europe, an EU-sponsored project, under the guidance of Prof HajoGrundmann, which was finalised in 2012. For this work she received a Travel Award for high potential scientists in the field of Hospital Epidemiology from the Society for Healthcare Epidemiology of America (SHEA). After a two year break, she engaged with the team of Prof Didier Pittet and Stephan Harbarth at Geneva University Hospitals to continue her academic career in the field of AMR in Europe. Her field of interest is the overlap between academic research and evidence-based health policies. She is currently involved in different European projects that aim to maintain and improve accessibility to effective antibiotics; COMBACTE-NET/MAGNET/CARE (IMI funded projects with EFPIA in-kind contributions). She also works as a statistical reviewer for The Lancet. Her work has resulted in several international publications, and multiple presentations at international conferences.
Disclosure of Interest: M. De Kraker Grant/Research support from: IMI - COMBACTE 115523/115620/115737
|GREENE||Linda||Linda R. Greene, RN, MPS, CIC, FAPIC is the Infection Prevention Manager for UR, Highland Hospital in Rochester, NY. Linda has 25 years’ experience in infection prevention. Linda has authored or coauthored several peer review publications in nursing and infection prevention journals, text book chapters and implementation guides. Linda was the APIC representative to the SHEA Compendium sections on VAE and SSIs. Prior to assuming the 2017 role of APIC president , Linda served in various leadership capacities in APIC including president of her local chapter, president of the New York State APIC Council and as an APIC board member and secretary of the APIC Board of Directors. Linda was lead author for APIC’S Position Paper on Healthcare Worker Influenza Immunization as well as APIC’S Position Paper on Electronic Surveillance for HAIs. Linda was a representative on the American Nurses Association CAUTI Prevention tool and serves as National Faculty for several national HAI reduction projects. She has served on several advisory panels and has received several awards in infection prevention, leadership, and nursing, and has lectured extensively at the state, national, and international level. No Conflict of Interest|
|GYSSENS||Inge|| Hasselt University, Belgium Department of Medicine, Radboud University Medical Center, Nijmegen, the Netherlands|
Department of Infectious Diseases & Immunity at Jessa Hospital, Hasselt, Belgium
Inge C Gyssens, MD PhD is professor of Infectious Diseases at Hasselt University, Belgium and is affiliated for research and teaching at the Department of Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. She is head of the Department of Infectious Diseases & Immunity at Jessa Hospital, Hasselt, Belgium.
She obtained her MD from Antwerp University, Belgium, where she completed her training in Internal Medicine after serving as a tropical doctor in NW Africa for 5 years. She trained in Infectious Diseases at Leiden University and obtained her PhD degree from Nijmegen University. From 1992 to 2007 she was appointed at Erasmus University Medical Center in Rotterdam and was Director of the Infectious Diseases Fellowship Training Program. Professor Gyssens’ research interests focus on optimizing antimicrobial therapy, and innate immunity of infectious disease. She has conducted audits and intervention studies in Antimicrobial Stewardship both in high- and low-resource countries. She is currently work package leader of two European projects, the Innovative Medicines Initiative (IMI) DRIVE-AB (Driving Reinvestment in R&D and Responsible Antibiotic Use) and the Horizon 2020 FAPIC (Fast Assay for Pathogen Identification and Characterisation) project.
She served as chair of the ESCMID Study Group for Antibiotic Policies, has been the National Delegate for the focal point of Antimicrobial Resistance Netherlands, European Centre for Disease Prevention and Control (ECDC), was expert for WHO and EMA and is associate editor on the Clinical Microbiology & Infection (CMI) Editorial Board. She has published 135 cited peer reviewed papers and nine chapters in edited books.
Disclosure of Interest: None Declared
|HERNANDEZ DE MEZERVILLE||Marcela||Epidemiology and InfectionPrevention and Control Unit, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera" , San José, Costa Rica Pediatric Infectious Diseases specialist, Trained at University of Toronto, Hospital For Sick Children. Currently works as The Epidemiology and Infection Prevention and Control Unit Coordinator, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera", Costa Rica. Disclosure of Interest: None Declared|
|HERWALDT||Loreen||Dr. Loreen Herwaldt graduated from Grinnell College in 1973 and from the University of Wisconsin School of Medicine in 1977. She did a residency in Internal Medicine (1977-1980) and a fellowship in Infectious Diseases (1982-1987) at Washington University in St. Louis. She was an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention from 1980-1982. She joined the faculty of the University of Iowa Carver College of Medicine in 1987 and is now Professor of Internal Medicine and Professor of Epidemiology in the University of Iowa College of Public Health. She is also the Hospital Epidemiologist at the University of Iowa Hospitals and Clinics. Dr. Herwaldt does research on healthcare-associated infections, particularly Staphylococcus aureus infections and surgical site infections, and other adverse outcomes of medical care. She recently completed an AHRQ-funded study to develop and assess preoperative screening for nasal S. aureus carriage and decolonization of carriers among patients undergoing cardiac operations or hip or knee replacements. She is currently conducting a followup study to assess the effectiveness of the prevention bundle components. She is also interested in the role of narrative in health care and in patient-clinician communication. She published a book entitled Patient Listening that presents patients’ stories of getting healthcare. Dr. Herwaldt previously served on the board of directors for the Society for Healthcare Epidemiology of America (SHEA). SHEA has honored her with its Young Investigator award and the 2012 Mentor-Scholar Award. Dr. Herwaldt edited the first edition of the textbook A Practical Handbook for Hospital Epidemiologists (now called Practical Healthcare Epidemiology). She has taught in the SHEA/CDC and the ESCMID/SHEA hospital epidemiology courses. She is currently chair of the SHEA Nomination Committee and a member of the ICAAC Planning Committee.|
|HOPMAN||Joost|| Medical Microbiology/Unit Infection control, Radboud University Medical Center, Nijmegen, Netherlands|
Since 6 years Joost is working as a consultant microbiologist and Head of the IPC unit at Radboud University Center, the Netherlands. He is strongly committed to improve infection control in the Netherlands and in low/middle income countries.
In 2014 and 2015 he has worked on a part-time basis as a IPC consultant for W.H.O. in the Ebola outbreak response. He has worked at W.H.O. headquarters as well as in Sierra Leone. His work at HQ resulted in a co-authorship of several W.H.O. guidelines as well as a W.H.O. teleclasses. His research projects are focusing on the IPC in low-resource settings and the role of the environment as a potential source of microorganisms. Reducing environmental contamination in low resource settings can strongly contribute to the reduction of hospital associated infections in those settings. Since 2013 he has been lecturing IPC in South Africa at the Stellenbosch University. This resulted in 2015 in the appointment as a senior lecturer in community health at the Stellenbosch University, South Africa. Since 2016 he is an advisory board member of ICAN (Infection Control Africa Network). In 2016 he was elected as one of the International SHEA ambassadors and was awarded with the Radboud medal for young potentials. In 2017 he will be the global IPC lead for Doctors without Borders Amsterdam.
Disclosure of Interest: None Declared
|HUTTNER||Benedikt|| BenediktHuttner is an infectious diseases specialist interested in antimicrobial stewardship, both in his clinical practice as well as in his research activities. After having finished his medical studies in Munich (Germany) in 2002 he trained in internal medicine in Bellinzona (Switzerland) and in infectious diseases in Zurich and Geneva (Switzerland). He is a member of the infection control team (SPCI) at HUG since 2007. Between 2010 and 2012 he spent two years in Salt Lake City (USA) in the context of a research fellowship. Since 2014 he is also attending physician at the division of Infectious Diseases at HUG and since 2016 “Privat-Docent” at the Faculty of Medicine of the University of Geneva. Other research interests besides antibiotic stewardship in the inpatient and outpatient setting concern the decolonisation of multdrug-resistant Gram negative organisms.|
Disclosure of Interest: None Declared
|KAYE||Keith|| Professor of Internal Medicine|
Director of Clinical Research, Division of Infectious Diseases
University of Michigan Medical School
Dr. Kaye is a Professor of Medicine in the Division of Infectious Diseases and Department of Medicine at University of Michigan Medical School. He is the Director of Clinical Research in the Division of Infectious Diseases. Dr. Kaye’s particular academic interests and skills are epidemiology of and outcomes associated with multi-drug resistant bacteria; antimicrobial stewardship; infections in the elderly; surgical site infection; and device-related infections.
Dr. Kaye received his medical degree from the University of Pennsylvania and served his Internal Medicine residency and was an Infectious Diseases fellow at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 200 peer-reviewed articles and 18 book chapters and has presented numerous abstracts at national conferences. Dr. Kaye has dedicated his entire career to infection prevention and antimicrobial stewardship and is recognized as an international leader expert in these disciplines. He currently is the PI on 2 NIH-funded trials evaluating the treatment of infections due to extremely-drug resistant (XDR) Gram-negative bacteria.
|KILPATRICK||Claire|| S3 Global, London, United Kingdom |
In summary, @claireekt = #handhygiene #infectionprevention #implementation #globalhealth #communications #campaigns
Claire has been a consultant with WHO since 2008. For WHO, she leads the social marketing behaviour change campaign SAVE LIVES: Clean Your Hands, the unique initiative Private Organisations for Patient Safety, is integral to the development of guidance (hand hygiene, core components for IPC, surgical site infection prevention), implementation strategies and tools, and undertakes field work with a focus on assessment and enhancing regional and country collaborations. She previously worked at national level in public health, on development and implementation of policies, healthcare improvement strategies, national campaigning and outbreak management. She has held a number of other positions, including communications lead for the Infection Prevention Society and is currently on hifa.org’s social media group and the board of the Arab Countries Infetion Control Network. She is a graduate of University of Glasgow, is currently studying for a PhD, and does other stuff with other organisations too. Disclosure of Interest: C. Kilpatrick Grant/Research support from: GOJO Industries
|KINGSTON||Liz||Liz is a Lecturer and Senior Clinical Skills Labs Coordinator at the Department of Nursing and Midwifery at University of Limerick, Ireland. She is a graduate of University College Dublin with a BSc. Nursing and a Higher Diploma in Nurse Education. She graduated from Dublin City University with a Master’s Degree in Education and Training Management. She is currently a doctoral student at University of Limerick and is exploring hand hygiene practice among healthcare professionals and healthcare students. She is leader on infection prevention and control post-graduate education at the Department of Nursing and Midwifery at University of Limerick.She led an interdisciplinary team in the design of an interdisciplinarymodule, Infection Prevention and Control in Healthcare, the first of its kind in the mid-western region of Ireland. In 2011 she successfully coordinated and led a collaborative bid for a research grant to develop technology-based teaching and learning resources on the topic of infection prevention and control, resulting in the development of a suite of video-based learning resources on all aspects of standard precautions. She is a member of the Infection Prevention Society UK, and is a member of the International Editorial Board of the Journal of Hospital Infection and is a peer reviewer on a range of academic journals. Disclosure of interest: none declared.|
|KOLWAITE||Amy|| Centers for Disease Control and Prevention, Atlanta, United States |
Amy R. Kolwaite, ARNP, MS, MPH, is a nurse epidemiologist and a team lead in the International Infection Control Program in the Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, in Atlanta, Georgia. Ms. Kolwaite is part of a team that provides assistance to countries in the development and implementation of sustainable solutions to prevent and control healthcare-associated infections internationally. Ms. Kolwaite received her Bachelor of Science in Nursing at Auburn University, Auburn, Alabama, Master of Science at Arizona State University, Tempe, Arizona, and her Master of Public Health at the University of Arizona, Tucson, Arizona. She practiced as a Pediatric Nurse Practitioner at Phoenix Children's Hospital, Phoenix, Arizona, and Emory University, Atlanta, Georgia, where she specialized in Pediatric Critical Care and Emergency Medicine. She began her career at the CDC in 2010 as an Epidemic Intelligence Service Officer in the Field Assignments Branch, where she was assigned to the Kentucky Department for Public Health, Frankfort, Kentucky. She worked on monitoring and responding to communicable disease outbreaks and supported public health preparedness activities. From 2012-2013, she completed the CDC Preventive Medicine Fellowship on the global team in the Division of Viral Hepatitis, where she provided technical support to countries implementing viral hepatitis surveillance and prevention programs. Ms. Kolwaite joined the Division of Healthcare Quality Promotion's international program in April, 2015. As a team lead, she supports countries to enhance infection control programs, implement surveillance for healthcare-associated infections, build laboratory capacity to detect antimicrobial-resistant pathogens, and optimize antimicrobial use through stewardship programs. Disclosure of Interest: None Declared
|KLUYTMANS-VAN DEN BERGH||Marjolein||Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda Julius Center for Primary Care and Health Sciences, UMC Utrecht, Utrecht, Netherlands MarjoleinKluytmans - van den Bergh finished her medical training at Erasmus Medical Center, Rotterdam, the Netherlands in 1992. She started her training in Clinical Microbiology at Erasmus Medical Center, Rotterdam in 1994, and completed it in St. Radboud University Medical Center, Nijmegen, the Netherlands in 2000. She obtained an MSc degree in Epidemiology at the Netherlands Institute for Health Sciences, Erasmus University, Rotterdam, the Netherlands in 1999. Between 2000 and 2005 she was employed as clinical assessor at the Dutch Medicines Evaluation Board. Since 2006 she holds a position as educational coordinator and research scientist at the Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands. She is currently working on her PhD project on isolation strategies for extended-spectrum beta-lactamase-producing Enterobacteriaceae at the Julius Center, UMC Utrecht, the Netherlands. Disclosure of Interest: None Declared|
|LANDELLE||Caroline|| Infection control unit, CHU Grenoble Alpes, 2ThEMAS TIM-C UMR 5525, University Grenoble Alpes/CNRS, Grenoble, France |
After pharmaceutical studies, Caroline Landelle specialized in infection control and prevention in France and worked successively in Lyon (Prof. Philippe Vanhems) and Paris (Prof. Christian Brun-Buisson). She obtained a PhD in 2008. During her doctoral work, she studied the association between immunosuppression and incidence of nosocomial infections after septic shock. She joined the infection control team of Geneva University Hospitals (Prof. Didier Pittet; Prof. Stephan Harbarth) in 2011 as a research fellow. Caroline’s research focuses on transmission of pathogens and risk factors of nosocomial infection, including antiseptic resistance, in the critical ill setting. She is currently senior infection control practitioner at the Infection Control Unit of CHU Grenoble Alpes, France. Disclosure of Interest: None Declared
|LING||Moi Lin||Singapore General Hospital, Singapore, Singapore Dr Ling Moi Lin received her medical education at the National University of Singapore. She obtained her postgraduate training in Microbiology at the Victoria University of Manchester, is a member of the Royal College of Pathologists of Australasia, and is a certified professional in healthcare quality (CPHQ). She is currently the Director of Infection Control at the SGH where she played a key role in the development of infection control program in the hospital. She is the President of the Infection Control Association (Singapore) that was formed in 1999; and President of the Asia Pacific Society of Infection Control (APSIC). She was a Director on the Healthcare Quality Certification Board (HQCB) and its Asia Pacific representative from 2006-2007. She helped to set up the Healthcare Quality Society of Society in 2007 and is its founding President. She is a fellow of the Society of Healthcare Epidemiology of America (SHEA) and also a member of the Editorial Council of the International Journal of Infection Control and the Healthcare Infection journal. Her interests are in infection control, antimicrobial resistance, molecular epidemiology as well as quality improvement. She is an experienced trainer in infection control, quality improvement, LEAN and patient safety.|
|MAIWALD||Matthias||Matthias Maiwald is a Senior Consultant in Microbiology at KK Women's and Children's Hospital in Singapore and an Adjunct Associate Professor at the Department of Microbiology, National University of Singapore, and at Duke-NUS Graduate Medical School. He previously worked at the University of Heidelberg, Germany, subsequently at Stanford University, USA, and then at Flinders University in Adelaide, Australia. He holds a German board certification in medical microbiology, a Fellowship of the Royal College of Pathologists of Australasia, and is a Diplomate of the American Board of Medical Microbiology. He has two main areas of interest, one is the molecular detection and characterization of fastidious emerging pathogens, the other is infection control, with an emphasis on hand hygiene, skin antisepsis and the prevention of surgical site infections.|
|MARSCHALL||Jonas||Jonas Marschall, MD, is an infectious diseases physician and currently the director of the infection prevention program at Bern University Hospital, Switzerland. He also serves as adjunct faculty for the Division of Infectious Diseases at Washington University in St. Louis, USA, where he worked from 2006-2013 and from where he obtained a Masters in clinical investigation. Jonas’ research focus is on infectious disease epidemiology in the hospital, with special interest in urinary tract infections. Jonas has coauthored >80 peer-reviewed articles in the field and received several research grants. Most recently, he took the role as surveillance lead in a national pilot program on CAUTI prevention in Swit-zerland. Jonas also serves on the board of Swissnoso, an expert association of hospital epidemiolo-gists, and for Anresis, the Swiss antibiotic resistance network.|
|MONNET||Dominique||EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL, Solna, Sweden. Head, Antimicrobial Resistance & Healthcare-Associated Infections (ARHAI) Programme European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Dominique L. Monnet joined ECDC in October 2007 to lead ECDC’s Disease Programme on Antimicrobial Resistance and Healthcare-Associated Infections. He is also representing ECDC in the EU-US Transatlantic Task Force on Antimicrobial Resistance (TATFAR). Before joining ECDC, he worked in French hospitals, at the US Centers for Disease Control and Prevention (1993-1995) and at the Danish Statens Serum Institut (1997-2007) where he was coordinating surveillance of antimicrobial resistance and antimicrobial consumption in humans in Denmark. His research interests include surveillance of antimicrobial resistance and antimicrobial consumption, the relationship between consumption of antimicrobials and resistance, and the factors that affect antimicrobial usage, both in hospitals and in primary care.|
|VAN MOURIK||Maaike|| Medical Microbiology and Infection Control, UNIVERSITY MEDICAL CENTER UTRECHT, Utrecht, Netherlands |
Maaike van Mourik (1985) is a resident in Clinical Microbiology and a post-doctoral research fellow at the University Medical Center Utrecht. Her research focuses on surveillance methods for healthcare-associated infections, in particular the possibilities of automated surveillance using data stored in electronic health records. She works on developing automated surveillance methods for various HAI and implementing them in practice as well as investigating novel methods and definitions of HAI. Disclosure of Interest: None Declared
|NTHUMBA||Peter||Dr. Nthumba is a Consultant Plastic, Reconstructive and Hand surgeon at the AIC Kijabe Hospital in Kenya. He is the Vice-President of the Surgical Society of Kenya. Dr. Nthumba graduated with an MBChB from the University of Nairobi, in 1995, and obtained a Master of Medicine in Surgery from the same University. In 2004, he became a Fellow COSECSA. Between 2006 and 2008, he underwent training in Plastic and Hand Surgery at the Christian Medical College, Vellore, India. He undertook a Fellowship in Reconstructive Microsurgery in Valencia, Spain, for a year, before returning to AIC Kijabe Hospital, to develop the Plastic Reconstructive and Hand Unit. He was appointed Clinical Assistant Professor, Department of Plastic and Reconstructive Surgery, Vanderbilt University Medical Center in 2012, and is also Clinical Assistant Professor, Departments of Plastic Surgery at the College of Medicine Chattanooga, and the Ohio State University, USA. Dr. Nthumba was a member of the WHO SSI guidelines development group, which helped developed the WHO SSI prevention guidelines, published in November 2016. He is a member of OASIS Global, an NGO committed to bringing affordable and effective infection control practices to low and middle-income countries. Dr Nthumba has interests in research, surgical education, surgical infection and reconstructive microsurgery.|
|PARIENTI||Jean-Jacques|| Clinical Research Department and infectious disease consultant at Caen University Hospital, France|
Dr. Jean-Jacques Parienti is Professor of Public Health and Medical Director of the Clinical Research Department and infectious disease consultant at Caen University Hospital, France. He received his MD from Caen University Medical School and his PhD in Epidemiology from Paris XI. He completed his residency training in Public Health and his Infectious Disease fellowship at Caen University Hospital. Dr. Parienti´s editorial activities have included appointment to the Editorial Board of the Intensive Care Medicine and service as a peer-reviewer for numerous internal medicine, infectious diseases, and epidemiology journals. His scientific interests encompass patient safety, prevention of infections and antimicrobial resistance. In parallel, he developed innovative clinical research methodologies in the field of community interventions, such as the cluster cross-over design. He has authored or co-authored more than 140 peer-reviewed publications and textbook chapters and contributed to numerous guidelines and policies relevant to HIV therapy and healthcare-associated infection prevention.
Disclosure of Interest: None Declared
|PERENCEVITCH||Eli||Dr. Perencevich is a Professor of Medicine at the University of Iowa, Carver College of Medicine with appointments in the Divisions of General Internal Medicine and Infectious Diseases, as well as a secondary appointment in the Department of Epidemiology in the University of Iowa, College of Public Health. Perencevich is currently Director of CADRE (Center for Comprehensive Access & Delivery Research and Evaluation) at the Iowa City VA Health Care System, which is funded by the VA HSR&D service. Our research group is comprised of a methodologically diverse team of faculty, fellow and student investigators with backgrounds in infectious disease clinical practice, hospital epidemiology, epidemiology, medical anthropology, health psychology, spatial analysis, informatics and biostatistics. Research in the group focuses on preventing and treating infections in the healthcare environment. Our ultimate goal is to make hospital stays safer and free of infection. Major focuses areas for our research include: Developing methods to improve surveillance of hand hygiene compliance and testing novel interventions to improve compliance Developing and testing bundles of care to prevent surgical site infections Determining the comparative effectiveness of therapeutic options for multidrug resistant bacterial infections including methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) Understanding the environmental and geographic factors that increase the risk of MRSA and CRE infections Understanding the barriers and facilitators to adoption and implementation of infection prevention interventions Developing and testing innovative approaches for delivering comprehensive care for persons with HIV infection|
|PIRES||Daniela|| Infection Control Programme, Geneva University Hospitals and Faculty of Medicine, Geneve, Switzerland |
Biography / CV:Daniela Pires is a research fellow at the Infection Control Programme& WHO Collaborating Centre on Patient Safety at the University of Geneva Hospitals and Faculty of Medicine (Switzerland). Her main interest within infection control is hand hygiene. After finishing her medical studies in 2009 (University of Lisbon), she started her training in Infectious Diseases at Santa Maria Hospital (Lisbon). She has been working in Geneva since 2015, where she is developing her PhD. Her main aim is to define strategies to improve hand hygiene action quality and monitoring. She is also engaged in several projects aiming to promote hand hygiene worldwide. Additionally, she has been working in projects related to carbapenemase-producing Enterobacteriaceae epidemiology, Clostridium difficile asymptomatic carriage and assessment of National Infection Prevention and Control policies.
Disclosure of Interest: None Declared
|PLANTINGA||Nienke||Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands. Nienke Plantinga (1984) graduated in Medicine at the University Medical Center in Utrecht in September 2011. After two years of clinical experience in Intensive Care Medicine and Internal Medicine she started her PhD-project on selective decontamination in Intensive Care patients at the department of Epidemiology of Infectious Disease of professor MJM Bonten. Together with BastiaanWittekamp, she coordinates the “R-GNOSIS Decolonisation Strategies in ICU study”; a multicenter cluster-randomized trial in 13 hospitals in six European countries. In August 2017, she will start her training in Medical Microbiology.|
|REILLY||Jacquie|| Safeguarding Health through Infection Prevention (SHIP) research group, Insititue for Appllied Heath Research, Glasgow Caledonian University and Health Protection Scotland, HAI, AMR and IPC group, Health Protection Scotland, Glasgow, United Kingdom Jacqui is Lead Consultant for Healthcare Associated Infection (HAI), Antimicrobial Resistance (AMR) and Infection Prevention and Control (IPC) at Health Protection Scotland (HPS). In addition to having a clinical leadership and management role, she leads the national specialist epidemiology work. Having authored more than 120 peer-reviewed publications and contributed extensively to national and international infection guidelines, Jacqui is elected chair of the European Centre for Disease Control (ECDC) HAI net coordinating committee, a member of the Scottish Government AMR and HAI Strategic Group and the Public Health England AMR Delivery board and is the UK national focal point for HAI to ECDC. She is a fellow of the Faculty of Public Health (FFPH) of the Royal College of Physicians and a fellow of the Royal Society of Biology (FRSB) and has a joint appointment at Glasgow Caledonian University, where she is a Professor of Infection Prevention and lead for the Safeguarding Health through Infection Prevention (SHIP) research group:https://www.gcu.ac.uk/hls/staff/profjacquireilly/ |
Disclosure of Interest: None Declared
|ROSSEN||John|| Department of Medical Microbiology & Infection Prevention, University of Groningen, Groningen, Netherlands |
Dr. John W. A. Rossen has a 25-year history in molecular microbiology and more than 105 peer reviewed publications (> 60 in the last five years; H-index 28). He is Assistant Professor at the University of Groningen, PI in the research group “Genomics for Infection Prevention” of Prof. dr. Alexander W. Friedrich and head of the molecular unit which has recently implemented the use of next generation sequencing for routine clinical microbiology and infection prevention. The method is used to determine the genetic relationship between pathogens (used to guide infection prevention measures) and for the molecular detection and further characterization of (emerging) pathogens. This includes analyses for revealing (new) antibiotic resistance mechanisms and for determining the virulence of pathogens resulting in improved risk assessment and infection prevention. In addition, based on comparing whole genomes of bacteria, tailor-made diagnostic tests are developed used for specific detection of outbreak and or virulent bacterial strains. Nowadays his research is focused on implementing metagenomics into clinical microbiology. Several PhD students, Post-Docs and technicians work together to investigate not only patient samples but also samples taken from animals, food and water - thereby realizing the one health principle in microbiology. Currently, Dr. Rossen is involved in the supervision of 9 PhD students. He is secretary of the ESCMID study group for genomic and molecular diagnostics (ESGMD) and treasurer of the Dutch Society of Medical Microbiology. Disclosure of Interest: None Declared
|SAX||Hugo||Disclosure of Interest: None Declared|
|SCHULZ-STÜBNER||Sebastian|| Deutsches Beratungszentrum für Hygiene, Freiburg, Germany |
The author is boardcertfied in anesthesiology, critical care, emergency medicine, pain medicine and infection control and evironmental medicine. He is also certified in psychotherapy and quality management. While still practicing part time in anesthesia, emergency medicine and pain his main focus is his dedication as chief physician at the German consulting center for infection prevention and control (DeutschesBeratungszentrumfür Hygiene) in Freiburg, Germany. His research interest is infection control in anesthesia and critical care, psychological factors of hygiene compliance and medical hypnosis.
Disclosure of Interest: S. Schulz-Stübner Employee of: DeutschesBeratungszentrumfür Hygiene, Shareholder: DeutschesBeratungszentrumfür Hygiene, Other conflict with: Royalties from book publishing with Springer publ. Germany
|STEWARDSON||Andrew|| Andrew Stewardson is an infectious diseases physician with research interests in infection control, hand hygiene, and the epidemiology of antibiotic resistance. After completing his clinical training in infectious diseases in Australia, Andrew spent four years as a research fellow with the Infection Control Program at the University of Geneva Hospitals and during this time he also collaborated with the WHO Patient Safety program. He has undertaken post-graduate training in epidemiology and biostatistics at the University of Geneva (Geneva, Switzerland) and Harvard School of Public Health (Boston, US). He is currently national project manager with Hand Hygiene Australia. |
Disclosure of Interest: None Declared
|STORR||Julie|| IPC Global Unit, WHO, MORETON IN MARSH, United Kingdom |
Julie Storr (BN(Hons) RGN RHV MBA) qualified as a nurse and health visitor in 1990. She has over a decade of experience working for WHO on the development, implementation and evaluation of global improvement programmes, with a focus on behaviour change. Her current work straddles two WHO units – quality Universal Health Coverage and Global Infection Prevention and Control (IPC). Her technical and leadership expertise was called on to support WHO’s Ebola response and recovery efforts in 2014/15, with a focus on national IPC policy development in Sierra Leone. She co-lead the development of the recently published evidence based WHO Guidelines on the Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Julie supports a number of charities and non profitorganisations including being on the Steering Group of Health Information for All (HIFA) and leading its social media activity, and as a trustee of Peoples Uni. She was previously President of the Infection Prevention Society of the UK and Ireland, Assistant Director at the National Patient Safety Agency and Director of the seminal cleanyourhands campaign. Julie has authored a book (Perspectives and Perceptions of IPC – highly commended at the 2016 BMA Medical Book Awards), published widely in the academic literature and is peer reviewer of a range of academic journals including Globalisation and Health and Implementation Science, and on the international advisory board of the Journal of Infection Prevention. She is currently studying for a doctorate in public health (health care leadership and management) at Johns Hopkins Bloomberg School of Public Health, Baltimore.
Disclosure of Interest: None Declared
|SZTAJZEL||Josiane||Disclosure of Interest: None Declared|
|TACCONELLI||Evelina|| Division of Infectious Disease and Medical Director of the Comprehensive Infectious Diseases Center (CIDiC) at the University Hospital of Tübingen, Germany |
EvelinaTacconelli (MD, PhD) is Professor of Infectious Diseases, Head of the Division of Infectious Disease and Medical Director of the Comprehensive Infectious Diseases Center (CIDiC) at the University Hospital of Tübingen, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO and ECDC on antimicrobial resistance and infection control. Main areas of her scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. She is the ESCMID Education Officer for Infectious Diseases and Clinical Microbiology. She serves on the Editorial Board of the Lancet Infectious Diseases, Journal of antimicrobial chemotherapy, and Clinical Microbiology and Infection. Author and co-author of more than 150 papers listed in SCI-JCR and NIH Medline.
Disclosure of Interest: None Declared
|TARTARI||Emira|| WHO collaborating centre for Patient Safety, Infection Prevention &Control, University Hospitals of Geneva, Genève, Switzerland |
Ms. Ermira Tartari RN, MSc., is a Research Fellow in the Department of Infection Prevention and Control & WHO Collaborating Centre on Patient Safety at the University of Geneva Hospitals, Faculty of Medicine, with a particular interest in Hand Hygiene. Ermira is a PhD candidate in Global Health at the University of Geneva, with research focusing on Global burden of healthcare-associated infections: impact of the WHO Clean Care is Safe Care programme worldwide in collaboration with Infection Prevention and Control Global Unit at WHO. She is interested in identifying the most effective methods for preventing healthcare associated infections in healthcare settings. She serves as a Member of the International Society of Chemotherapy for Infection and Cancer (ISC), and board member for the Infection Prevention and Control working group.
Disclosure of Interest: None Declared
|THEURETZBACHER||Ursula|| Center for Anti-Infective Agents, Vienna, Austria |
Dr. Theuretzbacher is founder and principal of the Center for Anti-Infective Agents in Vienna, Austria, since 1988. A microbiologist by training, she dedicated her professional life to antibacterial and antifungal drug R&D as well as appropriate and optimized usage of these drugs. Her main areas of expertise are resistance and dosing issues from the early development phase to the use of old and new drugs in clinical practice. She currently focuses on R&D strategies and policies targeted at antimicrobial resistance.
Ursula Theuretzbacher is currently work package leader in the multinational collaborative EU funded project AIDA (Re-developing old antibiotics) and in the multinational public-private partnership project DRIVE-AB (Incentivizing antibacterial drug R&D, funded by the EU Innovative Medicines Initiative=IMI) and partner in the IMI project COMBACTE-MAGNET (Developing new molecules against Gram-Negative Infections). She is Past-President of the Society of Anti‐Infective Pharmacology (ISAP) and Founding President of the ESCMID (European Society of Clinical Microbiology and Infectious Diseases) PK/PD of Anti‐Infectives Study Group (EPASG). She is chair of a policy and scientific study group of the International Society of Chemotherapy (ISC), Member of the Executive Committee of the International Society of Infectious Diseases (ISID) and member of the ECCMID Programme Committee. She has published widely read text books on clinical microbiology and authored and/or co-authored reviews, book chapters, research papers on resistance, PK/PD, and antibacterial and antifungal agents.
Disclosure of Interest: None Declared
|TIMSIT||Jean-François|| Professor of intensive care medicine|
Direction of research Habilitation iepidemiology and clinical trials Head of the medical and infectious diseases ICU in Bichat university hospital Paris, France Research team : clinical and interventional epidemiology: DesCIDdescision science in infectious diseases control and care - Inserm / Université Paris Diderot UMR 1137 F75018 Paris France Fied of interest: sepsis, nosocomial infections, prevention, high quality databases, survival models
Disclosure of Interest: None Declared
|VOS||Margret||Med Microbiology, Erasmus MC, Rotterdam, Netherlands Margreet C. Vos (1961) studied at the Medical Faculty Erasmus Universiteit in Rotterdam, The Netherlands, from 1981 to 1988, Cum Laude. She was a resident for clinical microbiologist in Tilburg until 1995. Thereafter , she became a staff member in Rotterdam, Erasmus MC. Since 2012, she is a professor of Healthcare related Infections at the dept of Microbiology and Infectious Diseases. She is for almost twenty years now the chair of the local infection committees at the Erasmus MC, Rotterdam, a revalidation clinic and the Harbour Hospital. She received more than 50 invited lectures nationally and internationally and has more than 100- peer reviewed publications, most of them deal with infection prevention of MSSA/MRSA, the Search and Destroy strategy, hand hygiene, outbreaks and Hospital design. She has PhD students on MSSA, MRSA, surveillance, te building and technical hospital environment. outbreaks and Implementation Science. She is member or chair of many national committees or working groups concerning infection prevention in general or MRSA, Hospital design and infection prevention or quality in infection control or the laboratory.|
|WALSH||Tim||Prof. Tim Walsh has been studying AMR mechanism for over 20 years and now leads an active international research group of over 140 people in over 12 different LMICs studying the impact of AMR. He is director of BARNARDS, a very large international program examining the impact of AMR on the burden of neonatal sepsis in Pakistan, India, Bangladesh, Rwanda, South Africa, Nigeria (Abuja and Kano) and Ethiopia. He is also PI of DETER-XDR-CHINA, a study examining the spread and burden of AMR in public health sectors and hospitals in 11 Provencesin China. He holds an honorary chair at the Chinese Agricultural University and is an AMR advisor to the Chinese Government. He has also recently been awarded an MRC grant to establish an AMR surveillance system throughout Vietnam in collaboration with Oxford University and the Wellcome Trust Center in Hanoi. In addition to BARNARDS, he also has AMR studies in Karachi and Peshawar and has collaborative studies with MSF in Jijawa (Nigeria), Niger (Clean Kids Study) and has facilitated the design and construction of the MSF Microbiology/AMR lab in Jordan/Syria. His lab provides molecular support for the Russian Federation Reference Laboratory in AMR surveillance that covers Russia, Belarus and Kazakhstan. He also has clinical studies examining the burden of AMR in the community and hospitals San Paolo (Brazil), Chang Mai (Thailand) and Tanta (Egypt). Walsh has also been appointed on the Fleming Fund expert advisory panel.|
|WIDMER||Andreas|| Andreas F. Widmer, M.D., M.S., FSHEA, FIDSA |
Prof. Widmer earned his MD degree in Switzerland, where he completed his fellowship in internal medicine and infectious diseases. He founded also the subspeciality of “infection control” among ID specialists. He was trained in hospital epidemiology by R. Wenzel, in Iowa, IA, USA, where he completed his master degree in epidemiology at the University of Iowa. He is a core member of the “patient safety” program of the WHO, a past President of the Swiss Society for Hospital Epidemiology, and an editorial advisory board member of the journals “Clinical Infectious Diseases”, “Clinical Microbiology”, “Infection” and “Infection Control and Hospital Epidemiology”. Furthermore, he is a former board member of the Society for Healthcare Epidemiology of America (SHEA) and a member of the guidelines committee. Furthermore, he is a fellow of the Infectious Disease Society of America (IDSA), and the treasurer of the European Study Group on Nosocomial Infections (ESGNI). His research interests are the control of multiresistant pathogens such as MRSA, surgical site infections, in particular implant-associated infections, and C. difficile infections. His current position is deputy chief of the division of infectious diseases and hospital epidemiology, and head of hospital epidemiology at the University Hospital Basel, Switzerland. He is a co-founder and the current President of “Swissnoso”, the national reference center for the prevention of nosocomial infections and surveillance of surgical site infections.
|WING HONG||Seto||Relevant Qualifications & Training: Fellow of HK Academy of Medicine and HK College of Pathologist (Founding Fellow) MRCP (Member of Royal College of Physicians, United Kingdom) FRCPath (Fellow of Royal College of Pathologist, United Kingdom) Certificate in Infection Control (CDC, USA) Certified Professional in Healthcare Quality (CPHQ, USA) F1000 Prime Faculty Member since 2014 Position: Co-Director, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong Clinical Professor (Hon.), School of Public Health, The University of Hong Kong Consultant Advisor (Hon.) for Quality and Safety, HKU Shenzhen Hospital Brief Dossier: Professor WH Seto played a key role in initiating Infection Control in Hong Kong and started the local training course for Infection Control Practitioners in 1985. He is involved extensively in Infection Control education throughout China and the region and is the Founding President of the Asia Pacific Society of Infection Control. Besides being Honorary Professor for the University of Hong Kong and the Hong Kong Polytechnic University, he is also a visiting professor for the University of New South Wales. He was conferred honorary professorships by several universities in China including Honorary Professorship for Infection Control by the Military Postgraduate Medical College, PLA General Hospital (301) and the People’s Liberation Army of China has in addition appointed him honorary consultant for Infection control in 1999. He is also the past Chairman of the Infection Control Scientific Committee of the “Centre for Health Protection” in Hong Kong. Presently and has authored over a hundred and fifty research papers including the book “Infection Control for the Asian Healthcare Worker”. Many international societies had invited him to speak on Infection Control and they include the ICC, ICID, CDC (USA), ASM (USA), ICN (UK), Hospital Infection Society (UK), APIC (USA), SHEA (USA) and ICNA (Australia). The WHO has also regularly assigned him as advisor for various projects in Infection Control, Antibiotics Resistance and a core group member for the WHO Hand Hygiene guideline. He is also a member of the Emergency Committee of the IHR of the WHO, member of the Infection Control International Network and Director of WHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University of Hong Kong. He is also awarded the “Bronze Bauhinia Star” in 2004 and “Silver Bauhinia Star” in 2011 from the Hong Kong Government for his work in Infection Control in Hong Kong. In view of his years of involvement in Infection Control, he is also active in the related field of Quality Healthcare Management and is presently the President of the Asia Pacific Society of Quality Healthcare. For 2013 he is made a Meritorious Member of ISC (International Society of Chemotherapy) and also awarded The Yen Award for outstanding research in Infections Disease. For 2015, he wins the IFIC (International Federation of Infection Control) Martin S. Favero Award 2015. This award is to honor him for his lifetime contribution to global infection prevention.|